Table 3.
Occurrence of IDFS Events.
| IDFS events | Yes (n = 30) | No (n = 122) | P value |
|---|---|---|---|
| Chemotherapy | 0.17 | ||
| Yes | 22 (73%) | 104 (85%) | |
| No | 8 (27%) | 18 (15%) | |
| Menopausal | |||
| Premenopausal | 12 (40%) | 63 (52%) | 0.31 |
| Postmenopausal | 18 (60%) | 59 (48%) | |
| Lymph Node Metastasis | |||
| ≤3 | 13 (43%) | 70 (57%) | 0.22 |
| >4 | 17 (57%) | 52 (43%) | |
| NG | |||
| NG1, 2 | 14 (47%) | 42 (34%) | 0.29 |
| NG3 | 16 (53%) | 80 (66%) | |
| Diameter | |||
| <5cm | 15 (50%) | 40 (33%) | 0.09 |
| ≧ 5cm | 15 (50%) | 82 (67%) | |
| Ki-67 | |||
| <20% | 10 (33%) | 29 (24%) | 0.22 |
| ≧20% | 14 (47%) | 76 (62%) | |
| Unknown | 6 (20%) | 17 (14%) | |
IDFS, invasive-disease-free survival; NG, nuclear grade